PEG-CONTAINING CONJUGATES OF HGF-NK4 Russian patent published in 2007 - IPC A61K47/48 A61K31/765 A61K38/16 

Abstract RU 2293574 C2

FIELD: organic chemistry, chemical-pharmaceutical industry, medicine, oncology.

SUBSTANCE: invention relates to a conjugate containing N-terminal fragment of hepatic growth factor (HGF/SF) that consists of "pin-like" domain and four cringle-like regions of α-chain and one polyethylene glycol group of the general molecular mass about 20-40 kDa and of the formula -CO-(CH2)x-(OCH2CH2)mOR or wherein -CO-group forms an amide bond with one of amino-group of N-terminal fragment of hepatic growth factor wherein X means 2 or 3; or y means 1-10; m has value from about 450 to about 950; or n and p in common have value from about 450 to 950; R means (C1-C6)-alkyl. The growth factor shows improved properties and it can be used as a therapeutic agent in treatment of cancer and metastasis of tumor cells.

EFFECT: valuable medicinal properties of conjugates.

7 cl, 1 tbl, 4 dwg, 9 ex

Similar patents RU2293574C2

Title Year Author Number
NOVEL PHARMACEUTICAL COMPOSITION 2001
  • Apolon Papadimitriou
RU2281116C2
CONJUGATES OF ERYTHROPOIETIN AND POLYETHYLENE GLYCOL, PHARMACEUTICAL COMPOSITIONS (VARIANTS), METHOD FOR PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF DISTURBANCES AND METHOD FOR PREPARING CONJUGATE OR COMPOSITION 2000
  • Burg Jozef
  • Khil'Ger Bernd
  • Jozel' Khans-Peter
RU2232163C2
NEW FUNCTIONAL, HIGH-PURITY STABLE CONJUGATE OF GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) AND POLYETHYLENE GLYCOL WITH PROLONGED BIOLOGICAL ACTION, APPLICABLE FOR MEDICAL PURPOSES, AND BASED IMMUNOBIOLOGICAL AGENT 2010
  • Chernovskaja Tat'Jana Veniaminovna
  • Rudenko Elena Georgievna
  • Denisov Lev Aleksandrovich
  • Morozova Elena Leonidovna
  • Morozov Dmitrij Valentinovich
RU2446173C1
NOVEL FUNCTIONALLY ACTIVE, HIGHLY PURE, STABLE CONJUGATE OF INTERFERON α WITH POLYETHYLENE GLYCOL, REPRESENTED BY ONE PEG- NH-IFN POSITIONAL ISOMER, WITH IMPROVED IMMUNOGENICITY, WITH PROLONGED BIOLOGICAL ACTION, SUITABLE FOR MEDICAL APPLICATION, AND IMMUNOLOGICAL AGENT BASED THEREON 2010
  • Chernovskaja Tat'Jana Veniaminovna
  • Denisov Lev Aleksandrovich
  • Morozov Dmitrij Valentinovich
  • Rudenko Elena Georgievna
  • Klenova Angelina Vsevolodovna
RU2447083C1
PEG-CONTAINING POLYPEPTIDE T1249 2003
  • Belon Paskal' Sebast'Jan
  • Von' Dzhziob
RU2294938C2
PEG-MODIFIED HUMAN INTERFERON β-1a MOLECULE WITH ANTIVIRAL, IMMUNOMODULATORY AND ANTIPROLIFERATIVE ACTIVITY, WITH IMPROVED STABILITY, REDUCED IMMUNOGENICITY, IMPROVED PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS, SUITABLE FOR MEDICAL USE, AND IMMUNOBIOLOGICAL FORMULATION BASED THEREON 2013
  • Chernovskaja Tat'Jana Veniaminovna
  • Efanov Jurij Georgievich
  • Morozov Dmitrij Valentinovich
  • Rudenko Elena Georgievna
  • Korzhavin Dmitrij Valer'Evich
  • Ustjugov Jakov Jur'Evich
  • Ivanov Roman Alekseevich
RU2576372C2
PEGYLATED POLYPEPTIDE T20 2003
  • Belon Paskal' Sebast'Jan
  • Von' Dzhziob
RU2296769C2
PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING GROWTH HORMONE-ASSOCIATED DISEASES IN HUMANS 2014
  • Rau Kharald
  • Kindermann Zuzanne
  • Lessmann Torben
  • Rasmussen Grete Nerskov
  • Kherzel Ulrikh
  • Vegge Tomas
  • Sprogee Kennet
RU2689336C2
NEW VERSION OF EXENDIN OR ITS CONJUGATE 2010
  • Sjuj Majkl M.
  • Van Junsjan
  • Chzhan Inkhoj
  • Lo Sjaosu
  • Gun Njan'
  • Chzhan Litsze
  • Chzhou Sjantszjun'
RU2528734C2
METHODS FOR AMINO GROUP PEGYLATION TO OBTAIN SITE-SPECIFIC CONJUGATES OF PROTEINS 2016
  • Rosendahl, Mary S.
  • Mantripragada, Sankaram B.
RU2730848C2

RU 2 293 574 C2

Authors

Brandt Mikhaehl'

Papadimitriou Apollon

Dates

2007-02-20Published

2002-02-21Filed